{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:27:43Z","timestamp":1774459663806,"version":"3.50.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Most of the classical antiepileptic drugs (AEDs) such as lamotrigine (LTG) and levetiracetam (LEV) are known to potentially cause skin lesions and liver injury. This paper reports an unusual phenomenon that serum levels of unconjugated bilirubin (IBIL) abnormally increased after the successful treatment of AED-induced bullosa epidermolysis, regardless of the presence of genetic mutations associated with hepatocellular bilirubin metabolism. A 14-year-old female, who was suffering from epilepsy, presented to our hospital with fever and red papules all over her body. Based on histopathological examination of the skin biopsy specimen and a medical history of LTG and LEV use, toxic epidermal necrolysis (TEN) was confirmed. After methylprednisolone treatment for 29\u202fdays, the skin lesions showed retreated but drug-induced liver injury (DILI) aggravated. Serum biochemical test results revealed elevated levels of serum total bilirubin, conjugated bilirubin, IBIL, gamma glutamyl transpeptidase, alkaline phosphatase, total cholesterol, and total bile acid. B-ultrasound examination indicated cholecystitis. The upper abdominal magnetic resonance cholangiopancreatography was performed four times on her and revealed progressive dilatation of the biliary ducts and cholestasis. A whole-exon sequencing of the liver biopsy specimen revealed a heterozygous 1249G&amp;gt;A mutation in the <jats:italic>ATP binding cassette subfamily C member 2<\/jats:italic> gene and a heterozygous 211G&amp;gt;A mutation in the <jats:italic>UDP glucuronosyltransferase family 1 member A1<\/jats:italic> gene. Hepatobiliary protection regimen was administered for a total of 71\u202fdays to reduce serum bilirubin level and to relieve symptoms. Nevertheless, the patient developed chronic DILI. The serum IBIL levels showed limited response to the regimen and instead increased to as high as 344.6\u202f\u03bcmol\/L. After taking phenobarbital, the IBIL level decreased only to 270.2\u202f\u03bcmol\/L. However, we documented a strong inverse correlation between serum creatine kinase (CK) and IBIL levels, which has not been discussed in other reported cases of AED-induced liver injury. This case emphasizes that the precise interpretation of serum hepatobiliary indexes is important for differentiating energy imbalance from organic integrity. A combination of serum CK and IBIL may serve as a useful laboratory tool for DILI stage assessment.<\/jats:p>","DOI":"10.3389\/fmed.2025.1662795","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:30:31Z","timestamp":1759383031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["High serum unconjugated bilirubin levels following successful treatment of antiepileptic drug-induced bullosa epidermolysis: a case report and review of the literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Chen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.amsu.2020.11.036","article-title":"Lamotrigine induced toxic epidermalnecrolysis: a case report","volume":"60","author":"Kc","year":"2020","journal-title":"Ann Med Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e42654","DOI":"10.7759\/cureus.42654","article-title":"Phenytoin-induced toxic epidermal necrolysis","volume":"15","author":"Tunuguntla","year":"2023","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/hep.28270","article-title":"Drug-induced liver injury associated with Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: patient characteristics, causes, and outcome in 36 cases","volume":"63","author":"Devarbhavi","year":"2016","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.hepres.2004.07.005","article-title":"Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects","volume":"30","author":"Ieiri","year":"2004","journal-title":"Hepatol Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/s41467-024-45337-5","article-title":"Transport mechanism of human bilirubin transporter ABCC2 tuned by the inter-module regulatory domain","volume":"15","author":"Mao","year":"2024","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/s41467-024-46392-8","article-title":"Structural basis for the modulation of MRP2 activity by phosphorylation and drugs","volume":"15","author":"Mazza","year":"2024","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"115481","DOI":"10.1016\/j.celrep.2025.115481","article-title":"Bilirubin metabolism in the liver orchestrates antiviral innate immunity in the body","volume":"44","author":"Du","year":"2025","journal-title":"Cell Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0925-4439(98)00013-1","article-title":"Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert\u2019s syndrome and Crigler\u2013Najjar syndrome type II","volume":"1406","author":"Yamamoto","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1023\/a:1005552302264","article-title":"Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians","volume":"22","author":"Kimura","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s10038-022-01086-1","article-title":"Concurrence of novel mutations causing Gilbert\u2019 s and Dubin\u2013Johnson syndrome with poor clinical outcomes in a Han Chinese family","volume":"68","author":"Zhou","year":"2023","journal-title":"J Hum Genet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41397-020-0173-2","article-title":"Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican mestizo patients with epilepsy","volume":"20","author":"Ortega-V\u00e1zquez","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"11006","DOI":"10.3390\/ijms252011006","article-title":"Therapeutic options for Crigler\u2013Najjar syndrome: a scoping review","volume":"25","author":"Sambati","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3350\/cmh.2015.21.2.180","article-title":"Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report","volume":"21","author":"Im","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/nu15040863","article-title":"Creatine supplementation to improve sarcopenia in chronic liver disease: facts and perspectives","volume":"15","author":"Casciola","year":"2023","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1093\/rheumatology\/keac014","article-title":"Outcome predictors of immune-mediated necrotizing myopathy-a retrospective, multicentre study","volume":"61","author":"Wang","year":"2022","journal-title":"Rheumatology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1662795\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:30:31Z","timestamp":1759383031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1662795\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":15,"alternative-id":["10.3389\/fmed.2025.1662795"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1662795","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1662795"}}